Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MPO | P05164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23878783 | 1.00 | RAB9A (0.41) | RAB9AMPOALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL30622707 | 0.84 | KDM1A (0.59) | ALDH1A1LMNASMN1; SMN2SLC6A4KDM1A | |
| SCHEMBL18550498 | 0.84 | KDM1A (0.59) | ALDH1A1LMNASMN1; SMN2SLC6A4KDM1A | |
| SCHEMBL791988 | 0.84 | SLC6A4 (0.56) | ALDH1A1LMNASMN1; SMN2SLC6A4TSHR | |
| SCHEMBL10090153 | 0.84 | SMPD1 (0.47) | RAB9ATDP1KMT2A | |
| SCHEMBL19411241 | 0.76 | HPGD (0.41) | RAB9AMPOALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL12930189 | 0.76 | CES1 (0.71) | ALDH1A1BCHE | |
| SCHEMBL5484265 | 0.75 | LMNA (0.42) | RAB9AALDH1A1LMNASMN1; SMN2TDP1 | |
| SCHEMBL18890496 | 0.74 | KDM1A (0.53) | ALDH1A1LMNASMN1; SMN2SLC6A4KDM1A | |
| SCHEMBL578249 | 0.74 | HTR7 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220048869-A1 | PHENAZINE-BASED COMPOUND, ELECTROLYTIC LIQUID COMPRISING SAME FOR REDOX FLOW BATTERY, AND REDOX FLOW BATTERY | LOTTE CHEMICAL CORPORATION (KR) | 2022-02-17 | — | — | US | claimed |
| US-20220048869-A1 | PHENAZINE-BASED COMPOUND, ELECTROLYTIC LIQUID COMPRISING SAME FOR REDOX FLOW BATTERY, AND REDOX FLOW BATTERY | LOTTE CHEMICAL CORPORATION (KR) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220048869-A1 | PHENAZINE-BASED COMPOUND, ELECTROLYTIC LIQUID COMPRISING SAME FOR REDOX FLOW BATTERY, AND REDOX FLOW BATTERY | PRDX5, NDUFS5, CYBB | RAB9A 3543/4885MPO 87/4885ALDH1A1 678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.